Clinical Trials
7 trialsNCT06125106 2023-11-09
Prospective, Single-arm, Multicenter Clinical Study on Haploidentical Hematopoietic Stem Cell Transplantation in Patients With MRD Positive CD19+ALL Treated With Conditioning Regimens Containing Blinatumomab
Zhejiang University
Phase 1 Unknown
NCT05559450 2022-09-29
Blinatumomab as a Bridge to Allo-HSCT in HR BCP-ALL
The First Affiliated Hospital of Soochow University
Phase 2 Unknown
NCT04604691 2022-03-08
Blinatumomab in Pediatric B-cell Acute Lymphoblastic Leukemia (ALL) With Minimal Residual Disease (MRD)
Seoul National University Hospital
Phase 1 Unknown
NCT04334993 2021-05-07
Pediatric-type Therapy With Pre-transplant Blinatumomab for HR Patients - Phase II Study
Israeli Medical Association
Phase 2 Unknown
NCT04723342 2021-01-25
Acute Lymphoblastic Leukemia Treatment Protocol Moscow-Berlin 2019 Pilot
Federal Research Institute of Pediatric Hematology, Oncology and Immunology
Phase NA Unknown
NCT04688983 2020-12-30
EWALL-Ph-03
Cardiff University
Phase 2 Unknown
NCT02744768 2018-03-22
D-ALBA Frontline Sequential Dasatinib and Blinatumomab in Adult Philadelphia Positive Acute Lymphoblastic Leukemia
Gruppo Italiano Malattie EMatologiche dell'Adulto
Phase 2 Unknown